BioWorld® - Medical Device Daily

BioWorld Industrial Biotechnology StatReport: Immediate and Comprehensive Industry Information
Genzyme Virotech GmbH--Germany
Genzyme Hellas LLC--Greece
Genzyme Europe BV Kepviselet--Hungary
Genzyme Ireland Ltd.
Genzyme Italy
Genzyme Polska Sp. z o.o.--Poland
Genzyme Portugal
Genzyme Barcelona
Genzyme Madrid
Genzyme GmbH--Switzerland
Genzyme Sygena--Switzerland
Genzyme Cambridge--U.K.
Genzyme Ltd.--U.K.
Genzyme Oxford--U.K.
Verigen Australia Pty. Ltd.--Australia
Genzyme China
Genzyme Asia Ltd.
Genzyme Tokyo
Genzyme Korea
Genzyme Singapore Pte. Ltd.
Genzyme GmbH Russia
Genzyme Taiwan
INVESTMENTS: Genzyme Clinical Partners LP--reacquired the assets for 1.4M shares of
Genzyme common stock (2/90)
RenaGel LLC--joint venture with GelTex Pharmaceuticals, Inc. to handle
development and commercialization of GelTex's RenaGel non-absorbed
phosphate binder
Abiomed Inc.--14%
50/50 joint venture with Genzyme Transgenics Corp.--$33M (7/97)
Joint venture with BioMarin Pharmaceutical Inc.
Joint venture with Pharming Group NV (7/98)
AGREEMENTS: Name Products Content of Agreement Date
Acadia
Acadia's cell-based collaborative 10/97
Pharmaceuticals screening technology screening
Inc.
and Genzyme's library
of more than 1M
compounds
agreement
Alcon Labs ophthalmic products supply agreement 12/86
(Nestle)
using hyaluronic acid
such as Surgicoat
Angiotech
identification,
strategic
5/06
Pharmaceuticals development and collaboration
Inc.
commercialization of
therapies for cancer
patients undergoing
surgical removal of
tumors
agreement
Aronex
Atragen development and 3/97
Pharmaceuticals
marketing
Inc.
agreement (9/93),
amended--
Genzyme has
option to
commercialize
ArQule Inc. drug candidates for
identifying cancer,
infectious diseases and
autoimmune/inflammato
ry diseases
development
agreement--ArQule
to provide
Genzyme with
access to Mapping
Array program for
identifying new lead
compounds against
Genzyme's targets
Copyright ©2006 AHC Media ® 176
4/97